Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Smyrna, Georgia


Purpose:

To evaluate over a period of 6 months the safety and the treatment satisfaction of newly prescribed levocetirizine in patients of age ≥ 2 years with persistent allergic rhinitis.


Study summary:

This is a non-interventional, prospective, post-authorization, multi-centre cohort study in patients treated with levocetirizine. The baseline data will be collected at the visit to the physician when levocetirizine is prescribed for the first time for the patient for Persistent Allergic Rhinitis. The data will then be collected during 2 visits occurring within the first 6 months of treatment, as usually scheduled in normal clinical practice in the Czech and Slovak Republics. This is after approximately 4 weeks and 6 months of treatment or earlier, if the treatment is stopped


Criteria:

Inclusion Criteria: - diagnosis of persistent allergic rhinitis - first prescription of levocetirizine for this diagnosis for this patient - age ≥ 2 years Exclusion Criteria: - indications other than those defined in inclusion criteria - history of allergic or anaphylactic reactions to levocetirizine or other derivatives and excipients included


NCT ID:

NCT00598780


Primary Contact:

Study Director
UCB Clinical Trial Call Center
+1 877 822 9493 (UCB)


Backup Contact:

N/A


Location Contact:

Smyrna, Georgia
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: January 21, 2018

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.